Category: Resource and Funding News

by Titilola Falasinnu, MHS, School of Population and Public Health, University of British Columbia Background Numerous research studies have explored the association between risk behaviors and infection with an STI. From a clinician’s perspective, the decision to recommend testing to a patient for a particular STI is usually informed by testing recommendations from public health… Read more »

The 2015 Island Health STOP HIV/AIDS and BBD Request for Proposals (RFPs) are now publically posted on BC Bid. Proposals will need to be received by 5 December 2014. Please follow the link below to find the three advertised RFPs: HIV and Blood Borne Disease Prevention and Harm Reduction Services HIV and Viral Hepatitis Testing… Read more »

Fraser Health – Substance Use: Moments to Milestones

This 30-minute video is an education resource for first responders, including police, paramedics, emergency room staff or anyone working with people who use substances.   It shows the remarkable, positive difference that can be made when people who use substance are approached in a manner that fosters respect, compassion and inclusion. The video focuses on… Read more »

by Michael Payne, MD, Medical Microbiology Resident Article reviewed F. Y. S. Kong, S. N. Tabrizi, M. Law, L. A. Vodstrcil, M. Chen, C. K. Fairley, R. Guy, C. Bradshaw, and J. S. Hocking. Azithromycin Versus Doxycycline for the Treatment of Genital Chlamydia Infection: A Meta-analysis of Randomized Controlled Trials. Clinical Infectious Diseases 2014;59(2):193–205.  … Read more »

Janssen Inc.’s simeprevir, brand name Galexos, in combination with peginterferon/ribavirin was just approved by BC’s PharmaCare for the treatment of chronic hepatitis C genotype 1 in patients with or without compensated cirrhosis and who have: never tried to treat their hepatitis C OR tried treatment but the virus came back OR tried treatment but weren’t… Read more »

Fact Sheets: 2012 HIV/AIDS Attitudinal Tracking Survey

The Centre for Communicable Diseases and Infection Control of the Public Health Agency of Canada, commissioned the “2012 HIV/AIDS Attitudinal Tracking Survey”.  The final report (2012 Report) is currently available on the Library and Archives website. The report describes findings of the third cycle of a public opinion research study (previous cycles in 2003 and… Read more »

CATIE’s HepCInfo Update 5.21

New and Noteworthy Interactions with transplant drugs added to simeprevir product monograph The U.S. Food and Drug Administration (FDA) recently approved revisions to the product label information for the direct-acting anti-viral medication simeprevir, known by the brand name Galexos in Canada. The revisions highlighted drug interactions with cyclosporine and tacrolimus, which are used to prevent… Read more »

PHAC: Report on Sexually Transmitted Infections in Canada: 2011

The Public Health Agency of Canada is pleased to present the 2011 edition of the Report on Sexually Transmitted Infections in Canada.  This report was made possible through the collaboration of all provinces and territories, whose continuous contribution to STBBI surveillance is appreciated and gratefully acknowledged. The Executive Summary will be posted online and a… Read more »

by Dr. Jason Wong, Clinical Prevention Services, BCCDC Background Provincial sexually transmitted infection (STI) data was used to describe the number of new STI (i.e., chlamydia, gonorrhea and infectious syphilis) case reports in BC overall (1991-2013) and to describe trends for the past ten years (2004-2013) by regional health authority, gender and age.   Findings… Read more »

The Public Health Agency of Canada is pleased to announce a call for membership applications for the Ministerial Advisory Council on the Federal Initiative to Address HIV/AIDS in Canada (MAC-FI) to fill vacant positions. MAC-FI is a council that provides unbiased, non-partisan, evidence-informed, targeted and strategic advice to the Minister of Health.  It is comprised… Read more »